-
Idorsia Establishes US Commercial Operations, Leadership Team
americanpharmaceuticalreview
July 27, 2020
Idorsia announced its expansion in the United States by establishing commercial operations. Located in Radnor, PA, the company has been established to further develop and embed Idorsia’s budding global commercial organization.
-
Idifarma Welcomes Director of Operations
contractpharma
May 29, 2019
Daniel Rivero joins the Spanish CDMO.
-
F1 Oncology Expands Operations
contractpharma
November 19, 2018
F1 Oncology, a biotechnology company discovering and developing adoptive cellular therapies (ACTs) for solid tumors, sai
-
Gilead expands operations in Cork, Ireland
pharmafile
May 25, 2018
Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and hepatitis.
-
WuXi Biologics Expands Operations
contractpharma
May 22, 2018
WuXi Biologics revealed plans to build an integrated biologics development, clinical and commercial manufacturing center in the city of Shijiazhuang, capital of Hebei province in northern China.
-
Fresenius alleges ‘blatant fraud at the very top level’ of Akorn operations
fiercepharma
May 08, 2018
Fresenius continues to hammer Akorn with allegations of fraud in its drug development and manufacturing as the German company battles to extract itself from its $4.3 billion buyout of the U.S. sterile injectables maker...